Pixee Medical’s Knee+ NexSight Receives the US FDA 510(k) Clearance for Knee Arthroplasty
Shots:
- The US FDA has granted 510(k) clearance to Knee+ NexSight, its AR-based total knee arthroplasty solution
- Knee+ NexSight projects a virtual display with voice control during knee arthroplasty, without the need of robot, console, or disposables, while delivering robotic-level accuracy with less invasive tools, reduced blood loss, & seamless workflow integration
- Knee+ NexSight supports most primary knee implants & personalized alignment, incl. kinematic alignment, with its software architecture allowing secure third-party integration & remote updates for increasingly data-driven operating rooms
Ref: Businesswire | Image: Pixee Medical | Press Release
Related News: Pixee Medical’s Knee+ NexSight Receives the European CE Mark for Knee Arthroplasty
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com


